BI
GSK icon

Ballast Inc’s GSK GSK Stock Holding History

Ballast Inc’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,703
Closed -$248K – 123
2023
Q4 		$248K Sell
6,703
-101
-1% -$3.63K 0.09% 108
2023
Q3 		$247K Sell
6,804
-16,403
-71% -$582K 0.1% 102
2023
Q2 		$827K Buy
23,207
+1,844
+9% +$66.1K 0.32% 57
2023
Q1 		$760K Buy
21,363
+1,543
+8% +$54K 0.31% 60
2022
Q4 		$696K Buy
19,820
+1,695
+9% +$56.5K 0.3% 61
2022
Q3 		$533K Buy
18,125
+4,291
+31% +$163K 0.26% 64
2022
Q2 		$752K Buy
13,834
+26
+0.2% +$1.44K 0.35% 57
2022
Q1 		$751K Buy
13,808
+2,096
+18% +$114K 0.29% 63
2021
Q4 		$645K Sell
11,712
-101
-0.9% -$5.25K 0.25% 63
2021
Q3 		$564K Buy
11,813
+403
+4% +$20.2K 0.24% 58
2021
Q2 		$567K Buy
11,410
+2,518
+28% +$121K 0.24% 59
2021
Q1 		$396K Buy
8,892
+2,093
+31% +$95K 0.19% 64
2020
Q4 		$312K Buy
6,799
+275
+4% +$12.6K 0.16% 72
2020
Q3 		$306K Sell
6,524
-522
-7% -$26.2K 0.17% 74
2020
Q2 		$359K Buy
7,046
+129
+2% +$6.62K 0.23% 69
2020
Q1 		$327K Buy
6,917
+1,607
+30% +$85.7K 0.23% 68
2019
Q4 		$311K Buy
5,310
+724
+16% +$40.3K 0.17% 80
2019
Q3 		$247K Hold
4,586
– – 0.15% 89
2019
Q2 		$232K Buy
4,586
+99
+2% +$4.97K 0.14% 90
2019
Q1 		$234K Buy
+4,487
New +$224K 0.15% 87
2018
Q3 		– Sell
-3,946
Closed -$201K – 96
2018
Q2 		$201K Buy
+3,946
New +$199K 0.16% 86

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ballast Inc's GSK Position: Q1 2024 in Review

Ballast Inc sold out of GSK (GSK) in Q1 2024, closing a stake of 6,703 shares — an estimated $248K sold.

Ballast Inc first reported a position in GSK in Q2 2018 and held it in 21 quarters. The position peaked at $827K in Q2 2023. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Ballast Inc reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • Ballast Inc sold 6,703 GSK shares in Q1 2024, an estimated $248K.
  • Ballast Inc first reported a position in GSK in Q2 2018 and held it in 21 quarters.
  • Ballast Inc's GSK position peaked at $827K in Q2 2023.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Ballast Inc's 13F filing for Q1 2024, filed 6 May 2024.